You are here

  • Home
  • Archive
  • Volume 12, Issue 8
  • Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington’s disease

Article Text

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington’s disease
  1. Hesitha Abeysundera1,
  2. Allan Campbell2 and
  3. Shanthi Sarma1
  1. 1 Department of Psychiatry, Queensland Health, Robina, Queensland, Australia
  2. 2 Department of Psychiatry, Queensland Health, Cairns, Queensland, Australia
  1. Correspondence to Dr Hesitha Abeysundera, drhesitha{at}hotmail.com

Abstract

This paper describes a patient who presented with treatment-resistant depression with comorbid anxiety symptoms in the context of Huntington’s disease (HD) and developed worsening movement disorder symptoms after commencing electroconvulsive therapy (ECT) for depression. The aim of this case report is to provide medical practitioners with a greater awareness of the possibility of worsening movement disorders when using ECT for depression in a patient with HD.

  • psychiatry (drugs and medicines)
  • neurology (drugs and medicines)
  • genetics
  • genetic screening / counselling
  • movement disorders (other than parkinsons)

https://doi.org/10.1136/bcr-2019-230389

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors This work was carried out in collaboration between all authors. HA is the consultant psychiatrist who treated the patient at the community mental health service. He designed the case report and helped in writing the report. SS is a consultant psychiatrist who helped write the paper. AC is a psychiatry registrar who researched the evidence for electroconvulsive therapy in Huntington’s disease and helped write the paper. All authors read and approved the final manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Patient consent for publication Obtained.